NURS 660: Psychopharmacology & Advanced Mental Health Final Exam 2026/2027 | Maryville Actual Questions with Verified Answers & Detailed Rationales | Grade A Study Guide

INSTANT PDF DOWNLOAD—This comprehensive study guide is specifically designed for Maryville University graduate nursing students (PMHNP, FNP) preparing for the NURS 660 Psychopharmacology and Advanced Mental Health Final Exam for the 2026/2027 academic year. Based on verified exam materials from top-selling student resources, this resource contains expertly verified practice questions and 100% correct answers with detailed rationales to help you master core psychopharmacology concepts and achieve a top score (Grade A+). This comprehensive guide covers all major topics tested on the NURS 660 Final Exam : Neuroanatomy of Fear & Anxiety : Amygdala (fear response, "remembers the stimuli" that leads to anxiety, increases efficiency of glutaminergic neurotransmission) ; hippocampus (memory coding/retrieval, re-experiencing in PTSD, internal fearmongering) ; parabrachial nucleus (respiratory response: shortness of breath, asthma, sense of being smothered) ; periaqueductal gray (motor response: fight/flight/freeze) ; locus coeruleus (cardiovascular response: increased norepinephrine, HR, BP) ; hypothalamus (sleep-wake switch, histamine/GABA regulation) ; prefrontal cortex (worry circuit, emotion regulation) ; anterior cingulate cortex (autonomic functions and cognition) ; orbitofrontal cortex (executive function) . Pain Pathways & Neurophysiology : A-beta fibers (small movements, light touch, vibrations) ; A-delta fibers (noxious mechanical stimuli, subnoxious thermal stimuli) ; C-fibers (bare nerve endings activated by noxious mechanical, thermal, chemical stimuli) ; allodynia (pain from a stimulus that does not normally provoke pain) ; hyperalgesia (increased pain from a stimulus that normally provokes pain) ; nociceptive pain (actual or threatened tissue damage) ; neuropathic pain (lesion or disease of somatosensory nervous system) ; central sensitization (increased responsiveness of nociceptive neurons in the CNS) ; peripheral neuropathy (diabetic neuropathy, postherpetic neuralgia) . Sleep-Wake Regulation & Brain Areas : Pineal gland (melatonin secretion) ; suprachiasmatic nucleus (circadian rhythm regulation) ; ventrolateral preoptic area (VLPO) – promotes sleep via GABA ; tuberomammillary nucleus (TMN) – promotes wakefulness via histamine ; sleep/wake switch (histamine from TMN promotes wakefulness, GABA from VLPO promotes sleep) . Benzodiazepines & Anxiety Treatment : MOA (binds to GABA-A receptors, positive allosteric modulator, increases frequency of chloride channel opening) ; indications for GAD and panic disorder ; contraindications (alcohol, opioids, sedating antihistamines) ; pregnancy risk (contraindicated) ; overdose treatment (Flumazenil – GABA receptor antagonist) ; benzodiazepine anxiolytics (Xanax, Valium, Ativan, Restoril) ; monitoring labs (liver function, CBC with long-term use) . Non-Benzodiazepine Anxiolytics & Hypnotics : Buspirone (Buspar) – 5HT1A partial agonist, does not affect GABA, enhanced serotonergic activity in amygdala, PFC, striatum, thalamus ; Zolpidem (Ambien) – selective GABA a1 subunit agonist ; Eszopiclone (Lunesta) – a1 isoform selective agonist ; Ramelteon (Rozerem) – melatonin receptor agonist M1/M2 ; Suvorexant (Belsomra) – dual orexin receptor antagonist ; medications for falling asleep (short half-life: Ramelteon, Rozerem) ; medications for staying asleep (Zolpidem ER, temazepam, Belsomra, eszopiclone) . Antidepressant Classes : SSRIs (sertraline, paroxetine, citalopram, escitalopram, fluoxetine) – block serotonin reuptake, side effects: GI upset, sexual dysfunction, serotonin syndrome ; SNRIs (venlafaxine, duloxetine, desvenlafaxine) – inhibit serotonin and norepinephrine reuptake, monitor BP ; TCAs (amitriptyline, nortriptyline) – anticholinergic effects, cardiac toxicity, require baseline EKG ; MAOIs (phenelzine, tranylcypromine) – dietary restrictions (tyramine-rich foods) → hypertensive crisis ; bupropion (Wellbutrin) – NDRI, no sexual side effects, seizure risk ; mirtazapine (Remeron) – alpha-2 antagonist, benefits: sleep, appetite . Mood Stabilizers & Antipsychotics : Lithium – therapeutic range 0.6-1.2 mEq/L (acute mania: 0.8-1.2; maintenance: 0.6-0.8), toxicity 1.5 (nausea, vomiting, ataxia, coarse tremor) ; valproate (Depakote) – therapeutic range 50-100 mcg/mL, hepatotoxicity, neural tube defects ; lamotrigine (Lamictal) – slow titration to prevent Stevens-Johnson syndrome ; carbamazepine (Tegretol) – autoinduction, drug interactions ; first-generation antipsychotics (haloperidol) – EPS, tardive dyskinesia, NMS ; second-generation antipsychotics (olanzapine, risperidone, aripiprazole, quetiapine) – metabolic syndrome monitoring (weight, glucose, lipids), prolactin elevation . Psychiatric Emergencies & Adverse Reactions : Neuroleptic Malignant Syndrome (NMS) – high fever (104°F), muscle rigidity, autonomic instability, elevated CK ; serotonin syndrome – onset within 24 hours of combining serotonergic agents, myoclonic jerks, hyperreflexia, mental status changes, autonomic instability ; agranulocytosis – clozapine requires ANC monitoring (general population ≥1,500/μL, BEN patients ≥1,000/μL), fever within 6 weeks of clozapine may indicate myocarditis . Neurotransmitters & Pathways in Schizophrenia : Mesolimbic pathway (increased dopamine → positive symptoms) ; mesocortical pathway (decreased dopamine → negative symptoms) ; tuberoinfundibular pathway (antipsychotics decrease dopamine → increased prolactin → decreased libido, sexual dysfunction, galactorrhea, gynecomastia) ; nigrostriatal pathway (EPS, tardive dyskinesia) . Sample Questions Include : "What is the role of the amygdala in anxiety?" → Plays a role in fear response; "remembers the stimuli" that leads to anxiety; increases efficiency of glutaminergic neurotransmission in lateral amygdala; strengthens fear conditioning at NMDA receptors "What is the response of the periaqueductal gray to fear?" → Fight, flight, or freeze response "What type of fibers are activated by noxious mechanical, thermal, or chemical stimuli?" → C-fibers "How do benzodiazepines help with anxiety?" → Target GABA neurotransmission via positive allosteric modulation (PAM); bind to GABA-A receptors; increase frequency of chloride channel opening "What is the antidote for benzodiazepine overdose?" → Flumazenil (Romazicon) "What is the mechanism of action of Buspirone (Buspar)?" → 5HT1A partial agonist; does not affect GABA; enhances serotonergic activity in amygdala, PFC, striatum, and thalamus "Which medications are best for problems staying asleep?" → Zolpidem ER, temazepam, Belsomra, eszopiclone (Lunesta) "What are the cardinal features of serotonin syndrome?" → Myoclonic jerks, hyperreflexia, mental status changes, shivering, fever, autonomic instability "What is the minimum ANC level required to start clozapine in the general population?" → 1,500/μL "What is the therapeutic range for lithium in acute mania?" → 0.8-1.2 mEq/L All questions include complete rationales based on current evidence-based practice, psychopharmacology standards, and Maryville University curriculum requirements. DOCUMENT ACCESS: This study guide is available as an instant digital download (PDF) immediately upon purchase. Fully text-searchable, printable, and accessible anytime through your user account. 100% satisfaction guarantee. Trusted by thousands of Maryville graduate nursing students for NURS 660 final exam preparation and mastering psychopharmacology competencies.